Search research articles
Contact Us
Filters
Showing results (91-100 of 98) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 98 results.
Diabetologia
|
February 1, 1987
Insulin Wakayama: familial mutant insulin syndrome in Japan
K Nanjo, M Miyano, M Kondo, et al.
Journal of Psychopharmacology (Oxford, England)
|
March 31, 2009
The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia
R M Abou El-Magd, H K Park, T Kawazoe, et al.
Bioorganic & Medicinal Chemistry
|
May 1, 1995
A novel series of orally active antiplatelet agents
J A Zablocki, F S Tjoeng, P R Bovy, et al.
Journal of Medicinal Chemistry
|
June 25, 1993
Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor
J A Zablocki, M Miyano, R B Garland, et al.
Kidney International. Supplement
|
July 21, 1999
Effect of simvastatin on the lipid profile of hemodialysis patients
O Nishikawa, M Mune, M Miyano, et al.
Science (New York, N.Y.)
|
August 5, 2000
Crystal structure of rhodopsin: A G protein-coupled receptor
K Palczewski, T Kumasaka, T Hori, et al.
Thrombosis Research
|
June 1, 1991
In vitro and in vivo effects of a peptide mimetic (SC-47643) of RGD as an antiplatelet and antithrombotic agent
N S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1991
Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749)
N S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 98) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 98 results.
Diabetologia
|
February 1, 1987
Insulin Wakayama: familial mutant insulin syndrome in Japan
K Nanjo, M Miyano, M Kondo, et al.
Journal of Psychopharmacology (Oxford, England)
|
March 31, 2009
The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia
R M Abou El-Magd, H K Park, T Kawazoe, et al.
Bioorganic & Medicinal Chemistry
|
May 1, 1995
A novel series of orally active antiplatelet agents
J A Zablocki, F S Tjoeng, P R Bovy, et al.
Journal of Medicinal Chemistry
|
June 25, 1993
Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor
J A Zablocki, M Miyano, R B Garland, et al.
Kidney International. Supplement
|
July 21, 1999
Effect of simvastatin on the lipid profile of hemodialysis patients
O Nishikawa, M Mune, M Miyano, et al.
Science (New York, N.Y.)
|
August 5, 2000
Crystal structure of rhodopsin: A G protein-coupled receptor
K Palczewski, T Kumasaka, T Hori, et al.
Thrombosis Research
|
June 1, 1991
In vitro and in vivo effects of a peptide mimetic (SC-47643) of RGD as an antiplatelet and antithrombotic agent
N S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1991
Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749)
N S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
Page
of 10